SynthesisFrontiers in oncology2026
Comparison of the effects of cognitive-supportive-relaxation multimodal psychosocial intervention on fear of cancer recurrence and psychological resilience in breast cancer patients: a network meta-analysis based on randomized controlled trials.
Synthesis in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Fear of cancer recurrence (FCR) is a highly prevalent and clinically significant psychological concern among breast cancer patients, which can substantially impair their physical and psychological well-being. Emerging evidence suggests that psychotherapeutic interventions exert heterogeneous effects on FCR and psychological resilience in this patient population; however, a paucity of comprehensive network meta-analyses has systematically compared the relative efficacy of diverse psychotherapies for FCR in breast cancer survivors. The present network meta-analysis was conducted to systematically evaluate and compare the effectiveness of various mind-body interventions in mitigating FCR and enhancing psychological resilience among breast cancer patients. Methods: Randomized controlled trials (RCTs) on different psychotherapeutic methods for psychological problems such as the fear of cancer recurrence, anxiety, and depression in breast cancer patients were retrieved by computer from PubMed, Embase, Cochrane Library, Web of Science, CNKI (China National Knowledge Infrastructure), VIP Database for Chinese Technical Periodicals, Wanfang Data Knowledge Service Platform, and Chinese Biomedical Literature Database. To ensure the novelty of the research, the retrieval time limit was set from January 2019 to March 2025. Two researchers screened the literature, extracted the data, and evaluated the methodological quality according to the inclusion and exclusion criteria. Network meta-analysis was conducted using RevMan 5.4 and Stata 17.0. Results: Nineteen eligible randomized controlled trials (RCTs) involving 11 interventions and 2214 participants were included. Network meta-analysis indicated distinct psychotherapeutic approaches had superior efficacy for specific psychological outcomes: couple skills training showed probabilistic advantages for fear of cancer recurrence (FCR, Fear of Cancer Recurrence Inventory); narrative therapy was effective for recurrence-related concerns; cognitive behavioral therapy (CBT) had probabilistic benefits in reducing fear of progression (Fear of Progression Questionnaire-Short Form) and enhancing positive psychological capital (Positive Psychological Capital Questionnaire); and both CBT and mindfulness therapy outperformed other interventions for anxiety and depression (Hospital Anxiety and Depression Scale). Sensitivity and subgroup analyses further validated the robustness of the findings and explored sources of heterogeneity. Subgroup analysis identified measurement time points and treatment status as the primary contributors to substantial overall heterogeneity (I²=91.9%, P<0.001), whereas measurement tools had no notable effect;leave-one-out sensitivity analysis showed the pooled effect size stably ranged from -1.44 to -0.63, with no single study driving overall results, confirming the robustness of core conclusions. Conclusion: Our findings underscore the outcome-specific advantages of different psychotherapeutic interventions for breast cancer patients, thereby supporting the adoption of a personalized, needs-based approach to address FCR, psychological distress, and resilience. Nevertheless, the current evidence is constrained by substantial heterogeneity in intervention protocols, variability in outcome measurement tools, and a relatively limited number of trials for certain interventions. Future high-quality RCTs with standardized intervention protocols, consistent outcome metrics, and long-term follow-up are warranted to validate these findings and inform the development of clinical practice guidelines for psychological support in breast cancer survivors. Systematic review registration: https://www.crd.york.ac.uk/PROSPERO/, identifier CRD420251009772.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.